Insmed
INSM
#754
Rank
โ‚น2.948 T
Marketcap
โ‚น13,439
Share price
20.58%
Change (1 day)
-25.39%
Change (1 year)

Market capitalization of Insmed (INSM)

Market cap: โ‚น2.948 Trillion

As of November 2026 Insmed has a market cap of โ‚น2.948 Trillion. This makes Insmed the world's 754th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Insmed from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น2.948 T-13.43%
2025โ‚น3.405 T218.77%
2024โ‚น1.068 T189.46%
2023โ‚น369.08 B64.78%
2022โ‚น223.99 B-6.67%
2021โ‚น240.00 B-3.23%
2020โ‚น248.01 B62.39%
2019โ‚น152.72 B115.34%
2018โ‚น70.92 B-53.49%
2017โ‚น152.48 B174.1%
2016โ‚น55.63 B-25.39%
2015โ‚น74.55 B52.68%
2014โ‚น48.83 B18.8%
2013โ‚น41.10 B256.38%
2012โ‚น11.53 B187.87%
2011โ‚น4.00 B-9.45%
2010โ‚น4.42 B-4.89%
2009โ‚น4.65 B69.26%
2008โ‚น2.74 B-30.36%
2007โ‚น3.94 B-0.06%
2006โ‚น3.94 B-33.03%
2005โ‚น5.89 B37.94%
2004โ‚น4.27 B-17.65%
2003โ‚น5.19 B626.6%
2002โ‚น0.71 B-88.23%
2001โ‚น6.07 B14.31%
2000โ‚น5.31 B

End of Day market cap according to different sources

On Nov 19th, 2026 the market cap of Insmed was reported to be:

โ‚น2.948 Trillion
by Nasdaq info icon info icon
โ‚น2.948 Trillion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
โ‚น26.569 T 801.18%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
โ‚น19.215 T 551.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น12.280 T 316.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น141.36 B-95.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
โ‚น70.10 B-97.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
โ‚น60.13 B-97.96%๐Ÿ‡บ๐Ÿ‡ธ USA